MLL2, also known as KMT2D (lysine methyltransferase 2D), isn't precisely a chemical class but rather a gene encoding a protein of significant importance in epigenetic regulation. As part of the SET domain-containing family of lysine methyltransferases, MLL2 plays a pivotal role in the methylation of histone H3, specifically at lysine 4 (H3K4). This post-translational modification of histones is a critical determinant of chromatin structure and function, influencing the transcriptional state of genes. H3K4 methylation, especially in its tri-methylated form (H3K4me3), is generally associated with transcriptionally active regions of the genome, marking promoters and enhancers that are conducive to gene expression.
The MLL2 protein is intricately structured, with multiple domains that allow it to interact with various co-factors and components of the transcriptional machinery. One of the notable aspects of MLL2's function is its association with complexes that drive transcriptional initiation and elongation. The protein's enzymatic activity, responsible for transferring methyl groups to histones, is mediated by its SET domain, a characteristic feature of histone methyltransferases. In addition to its primary role in histone methylation, MLL2 is involved in a myriad of cellular processes governing development, differentiation, and cellular response to external cues. Disruptions in MLL2's function or mutations in its coding sequence have been linked to alterations in transcriptional landscapes, leading to myriad cellular consequences. While MLL2's role in the broader context of cellular biology and its ability to target for MLL2 holds intrigue, the true depth of its function and its interplay with other cellular components remains an area of active research.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor. If PARD3A's function or interactions are modulated through specific kinases, staurosporine could indirectly affect its activity by altering these kinase-mediated pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C (PKC) inhibitor. PKC plays roles in various signaling pathways. If PARD3A operates within or is influenced by PKC signaling, this compound can potentially modulate its function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A phosphatase inhibitor that increases protein phosphorylation. If PARD3A's activity or interactions are regulated by phosphorylation, okadaic acid can indirectly enhance its function by maintaining its phosphorylated state. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Another cAMP analog that can influence cAMP-dependent signaling. If PARD3A operates in pathways influenced by cAMP, this molecule could modulate its function. | ||||||
Dimethyl Sulfoxide (DMSO) | 67-68-5 | sc-202581 sc-202581A sc-202581B | 100 ml 500 ml 4 L | $31.00 $117.00 $918.00 | 136 | |
Primarily a solvent, DMSO can affect protein conformations and cellular processes. Its presence could potentially modulate PARD3A's structure or interactions, although this would be a more non-specific effect. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
If PARD3A requires metal ions as cofactors or if its function is influenced by metal ion interactions, manganese can potentially modulate its activity. | ||||||